Karl-Eugen Hauptmann

Showing 1-14 of 14 articles

Use of a balloon-expandable transfemoral sheath in a TAVI cohort with complex access site - a propensity score matched analysis

Sedaghat A, von Dobbeler C, Sontag B, Sinning J, Fimmers R, Mellert F, Schiller W, Welz A, Grube E, Nickenig G, Hauptmann K-E, Werner N

October 20, 2015 | 10.4244/EIJY15M01_10

Outcome of patients after emergency conversion from transcatheter aortic valve implantation to surgery

Hein R, Abdel-Wahab M, Sievert H, Kuck K, Voehringer M, Hambrecht R, Sack S, Hauptmann K-E, Senges J, Zahn R, Mudra H

August 23, 2013 | 10.4244/EIJV9I4A73

Age-related differences in diagnosis, treatment and outcome of acute coronary syndromes: results from the German ALKK registry

Rittger H, Hochadel M, Behrens S, Hauptmann K-E, Zahn R, Mudra H, Brachmann J, Senges J, Zeymer U

February 21, 2012 | 10.4244/EIJV7I10A191

Six-month clinical and angiographic results of the STENTYS® self-apposing stent in bifurcation lesions

Verheye S, Ramcharitar S, Grube E, Schofer J, Witzenbichler B, Kovac J, Hauptmann K-E, Agostoni P, Wiemer M, Lefèvre T, Spaargaren R, Serruys P, Garcia-Garcia H, van Geuns R

September 30, 2011 | 10.4244/EIJV7I5A94

Assessment of the safety and performance of the STENTYS self-expanding coronary stent in acute myocardial infarction: results from the APPOSITION I study

Amoroso G, van Geuns R, Spaulding C, Manzo-Silberman S, Hauptmann K-E, Spaargaren R, Garcia-Garcia H, Serruys P, Verheye S

August 30, 2011 | 10.4244/EIJV7I4A71

Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study

Fajadet J, Wijns W, Laarman GJ, Kuck K, Ormiston J, Baldus S, Hauptmann K-E, Suttorp MJ, Drzewiecki J, Pieper M, Schultheiss H-P, Mauri L

November 15, 2010

Short and long term comparison (24 months) of an alternative sirolimus-coated stent with bioabsorbable polymer and a bare metal stent of similar design in chronic coronary occlusions: the CORACTO trial

Reifart N, Hauptmann K-E, Rabe A, Enayat D, Giokoglu K

August 15, 2010

Contemporary success and complication rates of percutaneous coronary intervention for chronic total coronary occlusions: results from the ALKK quality control registry of 2006

Werner G, Hochadel M, Zeymer U, Kerber S, Schumacher B, Grube E, Hauptmann K-E, Brueck M, Zahn R, Senges J

August 15, 2010

First-in-man (FIM) study of the Stentys™ bifurcation stent – 30 days results

Verheye S, Grube E, Ramcharitar S, Schofer J, Witzenbichler B, Kovac J, Hauptmann K-E, Agostoni P, Wiemer M, Lefèvre T, Serruys P, van Geuns R

March 20, 2009

One year results of a new in situ length-adjustable stent platform with a biodegradable Biolimus A9 eluting polymer: results of the CUSTOM-II trial

Stella P, Mueller R, Pavlakis G, De Bruyne B, Hauptmann K-E, Morice M, Chevalier B, Fajadet J, Sievert H, Grube E

August 20, 2008

Novel drug eluting stent system for customised treatment of coronary lesions: CUSTOM I feasibility trial 24 month results

Grube E, Sievert H, Hauptmann K-E, Mueller R, Gerckens U, Buellesfeld L, Ako J, Shimohama T, Costa M, Fitzgerald P

May 13, 2008

Safety and efficacy of multiple, overlapping polymer-based paclitaxel-eluting stents

Dawkins K, Grube E, Guagliumi G, Banning A, Zmudka K, Colombo A, Thuesen L, Hauptmann K-E, Marco J, Wijns W, Popma J, Weissman N, Koglin J, Russell ME

August 20, 2007

Randomised comparison of Nobori™, biolimus A9-eluting coronary stent with a Taxus®, paclitaxel-eluting coronary stent in patients with stenosis in native coronary arteries: the Nobori 1 trial

Chevalier B, Serruys P, Silber S, Garcia E, Suryapranata H, Hauptmann K-E, Wijns W, Schuler G, Fath-Ordoubadi F, Worthley S, Thuesen L, Meredith I, Bressers M, Nagai H, Paunovic D

February 20, 2007

Six-month results of a randomized study to evaluate safety and efficacy of a Biolimus A9™ eluting stent with a biodegradable polymer coating

Grube E, Hauptmann K-E, Buellesfeld L, Lim V, Abizaid A

May 20, 2005

1

Latest news

Three-year TAVI outcomes for BAV vs TAV

FREE ARTICLE - Dao Zhou et al.

January 20, 2022

Percutaneous management of left ventricular assist device outflow graft obstruction

FREE ARTICLE - Aleksandra Gasecka et al.

January 19, 2022

EuroCTO Club Consensus on Dual Lumen Microcatheters for CTO Recanalisation; Predicting Radial Crossover in ACS, the MATRIX score; DAPT duration for BRS; and more…

December 17, 2021

Lipid-rich plaque density and LDL-C in statin-treated vs statin-naïve patients

FREE ARTICLE - Rebecca Torguson et al.

January 17, 2022

Redo transcatheter mitral valve replacement in mitral annular calcification

FREE ARTICLE - Jennifer Jdaidani et al

January 13, 2022

TAVI vs SAVR in bicuspid aortic valve stenosis

FREE ARTICLE - Monil Majmundar et al.

January 12, 2022

Management of MR patients undergoing TMVI screening

FREE ARTICLE - Sebastian Ludwig et al.

January 7, 2022

Valvular disease